Clinical Trial Update: AKL 1 Asthma Study [Phase 2]

View source ↗

Summary

The AKL 1 asthma study (Phase 2) sponsored by the University of Aberdeen has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AKL 1

Snippet

Sponsor: University of Aberdeen | Conditions: Asthma | Phase 2 | Status: COMPLETED